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Abstract
Background: The dust mite Blomia tropicalis is an important source of aeroallergens in tropical areas. Although a 
mouse model for B. tropicalis extract (BtE)-induced asthma has been described, no study comparing different mouse 
strains in this asthma model has been reported. The relevance and reproducibility of experimental animal models of 
allergy depends on the genetic background of the animal, the molecular composition of the allergen and the 
experimental protocol.
Objectives: This work had two objectives. The first was to study the anti-B. tropicalis allergic responses in different 
mouse strains using a short-term model of respiratory allergy to BtE. This study included the comparison of the allergic 
responses elicited by BtE with those elicited by ovalbumin in mice of the strain that responded better to BtE 
sensitization. The second objective was to investigate whether the best responder mouse strain could be used in an 
experimental model of allergy employing relatively low BtE doses.
Methods: Groups of mice of four different syngeneic strains were sensitized subcutaneously with 100 μg of BtE on 
days 0 and 7 and challenged four times intranasally, at days 8, 10, 12, and 14, with 10 μg of BtE. A/J mice, that were the 
best responders to BtE sensitization, were used to compare the B. tropicalis-specific asthma experimental model with 
the conventional experimental model of ovalbumin (OVA)-specific asthma. A/J mice were also sensitized with a lower 
dose of BtE.
Results: Mice of all strains had lung inflammatory-cell infiltration and increased levels of anti-BtE IgE antibodies, but 
these responses were significantly more intense in A/J mice than in CBA/J, BALB/c or C57BL/6J mice. Immunization of 
A/J mice with BtE induced a more intense airway eosinophil influx, higher levels of total IgE, similar airway 
hyperreactivity to methacholine but less intense mucous production, and lower levels of specific IgE, IgG1 and IgG2 
antibodies than sensitization with OVA. Finally, immunization with a relatively low BtE dose (10 μg per subcutaneous 
injection per mouse) was able to sensitize A/J mice, which were the best responders to high-dose BtE immunization, 
for the development of allergy-associated immune and lung inflammatory responses.
Conclusions: The described short-term model of BtE-induced allergic lung disease is reproducible in different 
syngeneic mouse strains, and mice of the A/J strain was the most responsive to it. In addition, it was shown that OVA 
and BtE induce quantitatively different immune responses in A/J mice and that the experimental model can be set up 
with low amounts of BtE.
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Introduction
Exposure to house dust mite allergens is recognized as
the most important risk factor for the development of
allergic diseases [1-3]. Among the mites, Dermatophagoi-
des pteronyssinus and Blomia tropicalis are the main
sources of allergens in sub-tropical and tropical regions
of the world [4-6]. High frequencies of positivity to B.
tropicalis antigens in skin prick tests have been described
in asthma and rhinitis patients, such as 68.1% in Cuba [7],
91.6% in Venezuela [8], 73.3% in Taiwan [9] and 95.0% in
São Paulo, Brazil [10]. There is evidence that allergens
from B. tropicalis are distinct from, and bear only low to
moderate cross-reactivity to allergens from Dermatopha-
goides sp. [11]. For instance, antibodies from allergic
patients against the main B. tropicalis allergens (proteins
of 14.3 and 27.3 kDa) do not inhibit the binding of anti-D.
pteronyssinus  antibodies to D. pteronyssinus antigens
[4,9,11]. Thus, sensitization to B. tropicalis allergens is
considered an independent and important cause of
allergy [4,8]. These findings justify studies on species-
specific diagnosis and immunotherapy for B. tropicalis
allergy in regions where this species occurs alone or con-
comitantly with D. pteronyssinus.
Animal models that mimic the immunological and pul-
monary inflammation features observed in human
asthma are important tools to dissect the basic cellular
and molecular mechanisms involved in the initiation and
control of allergy [12]. Conventional models of allergic
asthma rely on the sensitization of experimental animals
to ovalbumin (OVA). However, in humans, most cases of
asthma are due to aeroallergens, and OVA-induced
asthma is far from being a common event. Thus, experi-
mental asthma models using common allergens might be
more relevant tools to the study of human asthma [13].
Despite the bulk of work done in humans on mite-spe-
cific allergy, data on allergic responses to B. tropicalis
antigens in murine models are scarce [14-16]. These
works were carried out using single (A/Sn or BALB/c)
mouse strains, and, to the best of our knowledge, no work
comparing the allergic response to B. tropicalis antigens
in different mouse strains has been done so far. Experi-
mental data indicate that inbred mouse strains differ in
their ability to mount an allergen-induced asthmatic
response [17,18]. Mice of some strains develop an intense
airway hyperreactivity, eosinophilia and IgE production,
while others fail to produce allergic responses [18].
The first objective of the present work was to study the
murine allergic response to B. tropicalis using a short-
term immunization protocol. The following parameters
were used to measure the immune response in mice of
four inbred strains (CBA/J, BALB/c, A/J and C57Bl/6): (i)
the total number of leukocytes and eosinophils in the
bronchoalveolar lavage fluid (BALF); (ii) the concentra-
tion of IL-4 and IL-13 cytokines and eosinophil peroxi-
dase (EPO) in the BALF; (iii) the serum levels of anti-B.
tropicalis  IgE antibodies. BtE-immunized mice of the
most responsive strain (A/J strain) were then assessed for
the presence of intra-bronchial mucous, airway hyperre-
sponsiveness (AHR) to methacholine challenge and
inflammatory cell infiltration in lung tissue. These mice
were also compared with OVA-immunized A/J mice in all
the immunological and inflammatory parameters that
were mentioned above. As a second objective of the pres-
ent work, mice of the best-responder strain were immu-
nized with relatively low doses of BtE aiming at obtaining
a low allergen-dose, short term murine model of respira-
tory allergy to B. tropicalis that reproduced many immu-
nological and pathological features of the human disease.
Materials and methods
Animals
Eight to 10 week-old CBA/J, BALB/c, A/J and C57BL/6
male mice, and 3 to 4 month-old Wistar rats, were bred
and maintained at the animal houses of the Gonçalo
Moniz Research Center, Oswaldo Cruz Foundation, Sal-
vador, Brazil, and of the Biomedical Sciences Institute,
University of São Paulo, São Paulo, Brazil. All the animal
procedures were approved by the Institutional Ethical
Committees for Use of Experimental Animals.
Blomia tropicalis extract
B. tropicalis house dust mites were collected from bed
dust in Salvador, Brazil, cloned and cultured with a pow-
dered fish food medium (Spirulina, Alcon Gold, São
Paulo, Brazil), and dry yeast (Fermipan, São Paulo, Bra-
zil), at 25°C and 75% humidity. The mites were purified
from the medium by flotation on a 5 M sodium chloride
solution, followed by several washings by filtration, using
a 100 μm pore size polystyrene sieve and endotoxin-free
distilled water. The washings were carried out until no
food residues could be seen under microscopy. The mites
were lysed in 0.15 M phosphate-buffered saline, pH 7.4
(PBS), in a blender (Waring Commercial, Torrington,
Connecticut, USA). Lipids from the lysate were extracted
and discarded by five or six ether extractions. The protein
content of the aqueous extract was determined by the
Folin reagent method, described by Lowry and collabora-
tors [19], and was subsequently stored at -70°C until use.
The amount BtE used in the experiments was standard-
ized by measuring its content in B. tropicalis Blo t 5 aller-
gen, measured by a commercially available capture ELISA
kit (INDOOR Biotechnologies, Charlottesville, VI, USA).
All used batches contained 30-40 ng of this allergen per
μg of protein.
Sensitization protocol
Groups of mice from different mouse strains were sensi-
tized to BtE by subcutaneous injections of 100 μg or 10 μgBaqueiro et al. Respiratory Research 2010, 11:51
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of BtE adsorbed to 1.6 mg of alum [Al(OH)3] gel (Sigma
Chemical Co., St. Louis, MO, USA) on days 0 and 7 and
challenged intranasally with 10 μg of BtE in 50 μl of saline
on days 8, 10, 12 and 14. Four different batches of BtE
were used in different experiments. Control groups
received only alum and were challenged with saline or
with BtE. In addition, groups of A/J mice were injected
with 100 μg of OVA (Sigma Chemical Co., St. Louis, MO,
U S A )  a ds o r bed  t o  a l u m  a n d  c h a l l e n g ed  wi t h  5 0  μ L  o f
saline containing 10 μg of OVA, as described above for
the BtE. The mice were painlessly killed 24 h after the last
allergen challenge.
Blood collection
Mice were deeply anesthetized by intraperitoneal injec-
tion with a solution containing ketamine (Ketamina
Agener; União Química Farmacêutica Nacional S/A, São
Paulo, Brazil) and chloral hydrate (Labsynth, São Paulo,
Brazil) and blood samples from the retro orbital plexus
were collected for serum antibody level determinations.
Bronchoalveolar lavage fluid collection and cell counting
The tracheas of the dead mice were cannulated and the
BALF collected in 0.5 mL of PBS containing 1% of bovine
serum albumin (Sigma Chemical Co., St. Louis, MO,
USA; PBS-BSA). An aliquot of the BALF cells was washed
three times by centrifugation, and the cell pellet resus-
pended in PBS-BSA. T otal cell counts were carried out
using a Neubauer chamber. Differential cell counts were
performed in light microscopy, according to standard
morphologic criteria, by counting, in a blinded fashion,
100 cells in cytospin preparations stained with Rosen-
feld's stain. Following centrifugation (400 g, 5 min, 4°C),
supernatants of the BALF were collected and stored at -
70°C for subsequent measurement of cytokine content
and the pellets were used for the measurement of eosino-
phil peroxidase (EPO) activity.
Eosinophil peroxidase activity in BALF
The EPO activity present in BALF was determined by
means of the colorimetric assay that was described by
Strath et al. [20]. Briefly, the BALF was incubated with an
erythrocyte-lysing buffer, consisting of 0.15 M NH4Cl, 1
mM KHCO3 and 0.1 mM EDTA, pH 7.4, and centrifuged.
The cell pellets were resuspended in PBS and lysed by
three successive freezing and/thawing procedures, and
then assayed for peroxidase activity in 96-well microassay
plates, in duplicates, using 6.6 mM H2O2 and 1.5 mM
orthophenylenodiamine (Merck, Whitehouse Station, NJ,
USA).
Cytokine assays
The BALF supernatants were stored at -70°C until used.
IFN-γ and IL-4, IL-10 and IL-13 concentration measure-
ments were assayed in commercial ELISA kits according
to manufacturer's instructions (Pharmingen, St. Diego,
CA, USA). Sensitivities were >5 pg/mL for IL-4, >2 pg/
mL for IL-10, >0.5 pg/mL for IL-13 and >0.03 ng/mL for
INF-γ.
Lung histology
After the BALF collection, the lungs were perfused, via
the heart right ventricle, to remove residual blood,
immersed in 10% phosphate-buffered formalin for 24 h,
followed by 70% ethanol, and embedded in paraffin. Tis-
sues sections of 5-μm were then stained with periodic
acid-Schiff (PAS) for the evaluation of mucus production.
A quantitative digital morphometric analysis was per-
formed using the application program Metamorph 6.0
(Universal Images Corp. Downingtown, PA, USA). The
circunference area of the bronchi in the PAS-stained area
was electronically measured and the mucus index was
determined by the following formula: Mucus index =
(PAS-stained area/bronquial cross-section area) × 100.
Determination of airway responsiveness
Airway responsiveness to increasing doses of inhaled
methacholine (3, 6, 12 and 25 mg/mL) in conscious unre-
strained mice was determined using a single-chamber,
whole-body plethysmograph (Buxco Electronics Inc.,
Wilmington, NC, USA), as previously described [21].
After each nebulization with methacholine, recordings
were taken for 5 min. Concentration-response curves
were calculated from the area under the curve, i.e. the
time integral of changes in airway resistance within 20
min [22].
ELISA for immunoglobulin isotypes
Serum anti-OVA or anti-BtE IgG1 and IgG2a antibodies
were measured using OVA- or BtE-coated microtitre
plates and biotin-conjugated anti-mouse IgG1 or anti-
mouse IgG2a, respectively (Pharmingen, St. Diego, CA,
USA), in conjunction with streptavidin-horseradish per-
oxidase, H2O2  and orthophenylenodiamine (Merck,
Whitehouse Station, NJ, USA). Total IgE was detected
using anti-mouse IgE-coated microtitre plates and biotin-
conjugated anti-mouse IgE (UNLB Southern Biotechnol-
ogy Associates, Inc., Birmingham, AL, USA), in conjunc-
tion with streptavidin-horseradish peroxidase, H2O2 and
orthophenylenodiamine. The antibody concentration was
obtained by interpolation into a curve obtained by con-
comitantly assaying different concentrations of mouse
IgE.
Passive cutaneous anaphylaxis reaction (PCA)
IgE antibody serum levels were estimated by PCA reac-
tion, as described by Mota and Wong [23]. In brief, 0.05
mL volumes of double dilutions (1/4 to 1/512) of individ-
ual mouse serum samples were intradermically injectedBaqueiro et al. Respiratory Research 2010, 11:51
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in the shaved dorsal regions of Wistar rats. After 48
hours, the rats received 2 mg of BtE in the tail vein,
diluted in 0.5 mL of saline containing 0.5 mg/mL of Evans
blue (Sigma Chemical Co, St. Louis, MO, USA). The rats
were painlessly killed 30 min later, and the reciprocal of
the highest serum dilution to produce a blue spot with
more than 5 mm of diameter was considered the PCA
titer.
Statistical analysis
The normality of the data was determined using the
Komogorov-Smirnov test. In order to verify differences
among more than two mouse groups, the results were
analyzed using the one-way ANOVA test and the Tukey's
post test. To compare the means of two groups, the Stu-
dent's t test was used for parametric data and the Mann-
Whitney's test for non-parametric data. All results were
considered statistically significant when p ≤ 0.05.
Results
Cytokine, EPO and leukocyte concentrations in BALF, and 
IgE serum levels, in four strains of mice following 
sensitization and challenge with B. tropicalis extract
Groups of mice were sensitized subcutaneously with BtE
co-adsorbed into alum on days 0 and 7, challenged intra-
nasally with BtE on days 8, 10, 12 and 14 and studied 24 h
later. Although the total cell counts in BALF were higher
in sensitized A/J mice than in the other sensitized mouse
strains, the differences were not statistically significant (p
> 0.05, ANOVA test; Figure 1A). Only in A/J and CBA/J
mice these total cell counts differed significantly from
their saline controls (p < 0.05; Tukey's test; Figure 1A).
Eosinophil numbers increased in the BALF of all sensi-
tized mouse strains, in relation to their saline control
(Figure 1B; p < 0.05 for BALB/c and p < 0.001 for A/J,
CBA/J and C57Bl/6; Tukey's test). No differences in num-
bers of macrophage, lymphocyte and neutrophils in the
BALF were observed among the mice of all four strains (p
> 0.05, ANOVA; data not shown). EPO activity levels in
BALF increased in all Bt-sensitized and challenged mice
and was higher in A/J, CBA/J and C57Bl/6 mice than in
BALB/c mice (p < 0.0001, p < 0.001, and p < 0.01, respec-
tively; Tukey's test; Figure 1C). Mice from all four studied
strains, sensitized and challenged with BtE had higher
levels of BtE-specific IgE as revealed by PCA, than the
alum- and saline-treated control mice (p < 0.001 for A/J,
p < 0.01 for CBA/J, and p < 0.05 for C57Bl/6 and BALB/c,
Tukey's test; Figure 1D). The differences in IgE titers in
BtE-sensitized and challenged mice in the four studied
mouse strains were not statistically significant (p > 0.05;
ANOVA), although A/J mice showed the highest titers,
followed by the CBA/J, C57Bl/6 and BALB/c mice. IFN-γ
and IL-10 concentrations in the BALF from BtE-sensi-
tized or saline-treated mice of all tested mouse strains
were low, and no statistically significant differences were
found among the studied groups and their negative con-
trols (data not shown). The production of IL-4 in BtE-
sensitized and challenged mice was higher in A/J when
compared with the other studied mouse strains (Tukey's
test, p < 0.05; Figure 1E); it was followed by the produc-
tion in CBA/J mice (p < 0.01, Tukey's test). BtE-sensitized
and challenged BALB/c or C57Bl/6 mice produced low
amounts of IL-4, which were similar to those produced by
their saline-treated control groups (p > 0.05, Tukey's test;
Figure 1E). IL-13 production was increased in A/J and
C57Bl/6 sensitized mice in comparison with the corre-
sponding control mice (p < 0.05, Tukey's test; Figure 1F).
Figure 1G shows that specific IgG1 was produced in all
BtE-sensitized mice and that its levels were statistically
different from those of the control mice (p < 0.001 for
BALB/C, C57Bl/6, and A/J mice, and p < 0.05 for CBA/J;
Tukey's test).
Animals that were not subcutaneously immunized with
BtE (they received instead control injections of alum),
and were subsequently challenged with BtE, did not differ
from control, non-immunized mice that were challenged
with saline, in any of the studied parameters (data not
shown).
Comparison of sensitization to BtE with sensitization to 
OVA, and presence of AHR and intra-bronchial mucus in A/J 
mice
Since A/J mice had more intense allergic responses, we
selected this strain to make a comparison between the
BtE-induced asthma model with the classical OVA-
induced asthma model. Animals sensitized and chal-
lenged with BtE showed higher levels of total cells and
eosinophils in the BALF than control mice (p < 0.001, Fig-
ure 2A, and p < 0.01, Figure 2B; Tukey's test). OVA-sensi-
tized mice also showed increased total cell (p < 0.05;
Figure 2A; Tukey's test) and eosinophil counts (p < 0.05;
Figure 2B; Tukey's test) in the BALF than the correspond-
ing control, saline-treated animals. EPO activity in BALF
was also higher in BtE-sensitized than in OVA-sensitized
and control mice (p < 0.05 and p < 0.001, respectively;
Tukey's test; Figure 2C). Sensitization with OVA (p <
0.001, Tukey's test) and BtE (p < 0.01, Tukey's test)
induced AHR, as compared with control mice (Figure
2D). The mucus index was higher in mice sensitized with
OVA than in mice sensitized with BtE or in the mice of
the saline-treated control group (Figure 3A; p < 0.001 and
p < 0.01, respectively; ANOVA and Tukey's test). Repre-
sentative micrographs of tissue sections of control, BtE-
or OVA-sensitized mice, stained with PAS, are shown
respectively in Figure 3B, C and 3D. The effect of BtE and
OVA sensitizations on total IgE and specific antibodies
levels are shown in Figure 4. Total IgE was higher in BtE-
sensitized animals (Figure 4A; p < 0001) and specific-IgE,Baqueiro et al. Respiratory Research 2010, 11:51
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IgG2a and IgG1 antibodies were higher in OVA-sensi-
tized group (Figure 4B-D; p < 0.05, Tukey's test).
Evaluation of a low-dose B. tropicalis extract protocol and 
lung inflammatory infiltration in A/J mice
After the observation that A/J was the best mouse strain
for BtE-induced asthma, we immunized these mice with a
low-dose (10 μg per injection) of BtE instead of the 100 μg
dose per injection used in the previous experiments. A
significantly larger number of cells was found in the
BALF of the mice sensitized with low-dose of BtE than in
the BALF of the saline control group (Figure 5A; p < 0.01;
Student's t test). Eosinophils were the main cellular type,
followed by neutrophils, found in the BALF of mice of the
BtE-sensitized group, and macrophages were found in
larger numbers in the saline control group (Figure 5B; p <
0.001 for differences in eosinophil counts between BtE-
sensitized and control group; Student's t test). The EPO
activity was higher in the BALF of BtE-sensitized mice
than in that of negative controls (Figure 5C; p < 0.01; Stu-
dent's t test). BtE-sensitized animals had more total
serum IgE as well as higher titers of anti-BtE IgE antibod-
ies than the saline control group (Figure 5D and 5E; p <
0.05; Student's t test and Mann-Whitney's test, respec-
tively). The effect of sensitization and challenge with 10
μg of BtE per injection on lung histology is seen in Figures
5F and 5G. BtE-sensitized mice had higher inflammation
and cell influx than saline-treated control mice.
Discussion
Most experimental models of respiratory allergy take
more than three weeks for completion [24,25] and use
OVA as allergen, due to its low cost, availability and well-
known immunological properties. However, results
Figure 1 Immune response of BALB/c, C57Bl/6, CBA/J and A/J mice sensitized with Blomia tropicalis extract (closed symbols) or injected 
with saline (open symbols). (A) Total leukocyte numbers in the bronchoalveolar lavage fluid (BALF). (B) Eosinophil numbers in the BALF. (C) Level 
of eosinophil peroxidase (EPO) activity in BALF. (D) Anti-B. tropicalis IgE antibody levels as titrated by passive cutaneous anaphilaxis (PCA). (E) IL-4 con-
centration in BALF. (F) IL-13 concentration in BALF. (G) Anti-B. tropicalis IgG1 antibody levels in blood. Each symbol corresponds to the result obtained 
from an individual animal. This data is representative of three independent experiments. *p < 0.05, **p < 0.01, ***P < 0.001; ANOVA and Tukey's test. 
P > 0.05 is not represented.
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obtained in murine experimental models of respiratory
allergy that use OVA as antigen differ from those
obtained in experimental models using mite allergens.
For instance, BALB/c mice respond vigorously to OVA in
terms of allergic inflammation but are low responders to
mite allergens [24]. Differences in allergenicity between
D. pteronyssinus and B. tropicalis antigens have also being
reported in experimental models of asthma [14]. In addi-
tion to allergen-dependent differences in intensity and
nature of the allergic responses, the genetic makeup of
the host seems to play an important role in murine mod-
els of respiratory allergy. On the other hand, a protocol
developed by Eum and collaborators [26], using OVA,
showed that shortening the duration of the allergic proto-
col did not affect the immunopathological features of the
experimental disease, when it was compared with classi-
cal protocols [24]. It is described, herein, the develop-
ment of a short-term protocol using B. tropicalis extract.
The allergenity of B. tropicalis antigens to mice has been
demonstrated before [14-16], although without a detailed
investigation using different strains of mice and different
doses of antigen. Using a short time model, we showed
that A/J mouse strain was the best responder in terms of
providing an experimental model of respiratory allergy. It
responded to immunization with the highest numbers of
leukocytes in the BALF, consisting mainly of eosinophils,
Figure 2 Allergic response of A/J mice sensitized with Blomia tropicalis extract (Bt E) or ovalbumin (OVA) or injected with saline (Control). 
(A) Total leukocyte numbers in BALF. (B) Differential leukocyte numbers in BALF. (C) Level of eosinophil peroxidase (EPO) activity in BALF. (D) Degree 
of airway responsiveness, as shown by the area under the curve (AUC) of the response to methacholine × time. *p < 0.05, **p < 0.01, and ***p < 0.001 
for the indicated tested groups (Tukey's test). P > 0.05 is not represented. In A and C, each symbol corresponds to the result obtained from an individ-
ual animal. In B and D, columns represent the mean result of 5 (B) or 8 (D) animals; the vertical bars represent the standard deviation of the means. 
Data from A, B, and C are representative of three experiments, and from D of two experiments.
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and had high levels of EPO activity in the BALF. Addi-
tionally, there were high levels of IL-4 and IL-13 in BALF
and increased levels of specific IgE in the sera. Finally,
they had intense AHR. A/J mice were also considered the
best responders to Dermatophagoides sp allergens among
four studied strains [25]. Karp and collaborators [27]
identified the gene encoding complement factor 5 (C5) as
a susceptibility locus for allergen-induced AHR in A/J
mice. This may be relevant to the human disease, as
Hasegawa and collaborators have reported that polymor-
phism in the C3, C3a receptor, and C5 genes affect sus-
ceptibility to bronchial asthma in human beings [28].
A short-term intranasal immunization protocol with
BtE, by itself, consisting of two intranasal instillations of
BtE per week, during 3 weeks, did not lead to detectable
allergic responses, indicating that the subcutaneous
immunization was required to induce the respiratory
allergy (data not shown). This is accordance to Takeda
and collaborators' observation that the intranasal instilla-
tion alone of BtE elicited an IgE antibody response only
when the antigen was continuously administered for a
period of over 24 weeks [15]. Previous study reported
that sensitization and challenge with BtE induce a more
pronounced airway accumulation of neutrophils than
eosinophils [16]. In our model, eosinophils were the pre-
ponderant cells in the airways, however similar numbers
of neutrophils and eosinophils were found in airways
when the animals were sensitized without alum (data not
shown). Thus, it appears that alum is required to achieve
fully polarized Th2 responses to BtE.
Our data also indicate that results obtained with OVA
sensitization cannot be extrapolated to other allergens.
Figure 3 Presence of mucus in bronchi of A/J mice sensitized with ovalbumin (OVA), Blomia tropicalis extract (Bt) or saline (Control). (A) Mu-
cus Index in the bronchi. Each column represents the mean of the mucus indexes of 5 mice, and the vertical bars represent the standard deviation of 
the mean. **p < 0.01, ***p < 0.001, ANOVA. (B-D) Representative lung sections stained with periodic acid-Schiff. (B) saline-injected group. (C) OVA-
sensitized group. (D) Bt-sensitized group. The data are representative of three independent experiments. P > 0.05 is not represented.Baqueiro et al. Respiratory Research 2010, 11:51
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Accordingly, sensitization of A/J mice to BtE led to pul-
monary inflammation with eosinophil infiltrate and to
total IgE increase, while OVA sensitization produced low
eosinophil and IL-4 responses in this mouse strain. On
the other hand, OVA sensitization led to higher mucus
production, and serum levels of specific IgE, IgG1 and
IgG2a than BtE sensitization.
Two key mechanisms for mucus production have been
identified: one activated by engagement of epidermal
growth factor receptor ligands (EGFR) and the other
dependent on IL-13 and STAT6 signaling [29-31]. EGFR
and STAT6 signaling were not investigated in the present
study, but we found increased IL-13 levels, in relation to
saline-treated controls, in BtE-sensitized A/J mice.
Figure 4 Total IgE and specific antibody levels in the blood of A/J mice that were sensitized with ovalbumin (OVA) or Blomia tropicalis ex-
tract (Bt E) or injected with saline (Control). (A) Total IgE. (B) Anti-Bt or anti-OVA IgE antibodies. (C) Anti-Bt or anti-OVA IgG2a antibodies. (D) Anti-
Bt or anti-OVA IgG1 antibodies. *p < 0.05, **p < 0.01, ***p < 0.001; Tukey's test. P > 0.05 is not represented. The data are representative of three inde-
pendent experiments.
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N o t a b l y ,  m i c e  s e n s i t i z e d  w i t h  BtE produced higher
amounts of total IgE than those sensitized with OVA, in
amounts similar to those observed with immunization
with helminth antigens [32]. This finding corroborated
the work of Takeda and collaborators [15], who found an
increase of total IgE in BtE- and cholera toxin- sensitized
mice. Dust mite proteins, such as Blo t 11, a paramyosin
from B. tropicalis that is homologue to a helminth mole-
cule, is responsible for the cross-reactivity found between
helminths and dust-mite species [33], and may be leading
to the non-specific IgE stimulation in BtE-sensitized mice
found in this and in the above mentioned work. Another
hypothesis is that proteases present in the BtE cleave
CD23, a negative regulator of IgE production [34].
Finally, we used a low dose of BtE (10 μg/per subcuta-
neous injection) and obtained results that were similar to
Figure 5 Effect of immunization with 10 μg per injection of B. tropicalis extract (Bt E) on the development of experimental respiratory al-
lergy in A/J mice. Control mice were injected with saline (Control). (A) Total cell count in the BALF. (B) Differential cell count in the BALF. (C) Levels of 
eosinophil peroxidase (EPO) in the BALF. (D) total serum IgE. (E) IgE anti-Bt antibody serum titers as determined by passive cutaneous anaphylaxis 
(PCA). Each symbol corresponds to the result obtained from an individual animal. (F and G) representative lung sections stained with hematoxylin and 
eosin of a saline-injected animal (F) and a Bt-sensitized animal (G). The data are representative of three independent experiments. *p < 0.05, **p < 0.01, 
***p < 0.001. A-D, Student's t test; E, Mann-Whitney's test. P > 0.05 is not represented.
Control Bt E
0
10
20
30
40
50 **
T
o
t
a
l
 
I
g
E
 
(


g
/
m
L
)
control Bt E
0
200
400
600 *
S
p
e
c
i
f
i
c
 
I
g
E
 
(
P
C
A
 
t
i
t
l
e
r
)
control Bt E
0.0
0.5
1.0
1.5
*
E
P
O
 
a
c
t
i
v
i
t
y
(
O
D
 
4
9
2
n
m
)
control Bt E
0
10
20
30
40
50
60
70
Bt E
control
**
T
o
t
a
l
 
n
u
m
b
e
r
 
o
f
 
c
e
l
l
s
 
x
1
0
4
/
m
L
A
C 
**
D  E
0
25
50
Macrophage Lymphocyte       Neutrophil Eosinophil
***
Bt E
Control
N
u
m
b
e
r
 
o
f
 
c
e
l
l
s
 
x
 
1
0
4
/
m
L
B
FG
Control Bt EBaqueiro et al. Respiratory Research 2010, 11:51
http://respiratory-research.com/content/11/1/51
Page 10 of 11
those obtained with a high dose (100 μg/per mouse) pro-
tocol, showing that BtE is able to sensitize A/J mice even
at small concentrations. This model may constitute a bet-
ter approximation to a natural allergenic sensitization, in
which allergic individuals tend to be exposed to low aller-
gen doses, independently of the entry route, than the so
far published experimental murine models, that use
higher BtE doses [[14-16] and [35]].
Conclusions
Altogether, we concluded that the short-term experimen-
tal model of BtE-induced asthma is reproducible in dif-
ferent mouse strains, although the A/J mice are the best
responders, and small quantities of BtE may be used to
sensitize this mouse strain. We also concluded that a
murine experimental model of respiratory allergy that
uses BtE as allergen differs quantitatively in immunologi-
cal and pathological parameters when compared with the
classical experimental model that uses OVA as allergen.
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